CAS 13642-52-9

Soterenol

Description:

Soterenol, with the CAS number 13642-52-9, is a synthetic compound primarily classified as a beta-adrenergic agonist. It is known for its potential therapeutic applications, particularly in the treatment of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Soterenol functions by stimulating beta-2 adrenergic receptors, leading to bronchodilation and improved airflow in the lungs. The compound is characterized by its ability to selectively target these receptors, which minimizes side effects commonly associated with non-selective beta agonists. In terms of physical properties, Soterenol is typically presented as a white to off-white solid, and its solubility profile indicates that it is soluble in organic solvents but may have limited solubility in water. The pharmacokinetics of Soterenol suggest a favorable absorption and distribution profile, making it a candidate for inhalation therapies. As with many pharmacological agents, the safety and efficacy of Soterenol are subject to ongoing research and clinical evaluation.

Formula: C₁₂H₂₀N₂O₄S

InChI: InChI=1/C12H20N2O4S/c1-8(2)13-7-12(16)9-4-5-11(15)10(6-9)14-19(3,17)18/h4-6,8,12-16H,7H2,1-3H3

SMILES: CC(C)NCC(c1ccc(c(c1)NS(=O)(=O)C)O)O

Synonyms:

• Soterenol [INN]
• 2'-Hydroxy-5'-(1-hydroxy-2-(isopropylamino)ethyl)methanesulfonailide
• 2'-Hydroxy-5'-(1-hydroxy-2-isopropylaminoethyl)methansulfonilid
• Soterenolum
• Soterenolum [INN-Latin]
• Unii-9364W7589B
• Methanesulfonamide, N-(2-hydroxy-5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)phenyl)-
• N-{2-hydroxy-5-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl}methanesulfonamide

Soterenol

CAS: 13642-52-9

Soterenol is an adrenergic beta-2 agonist used as bronchodilator and has a number of gastrointestinal side effects.

Formula: C₁₂H₂₀N₂O₄S

Color and Shape: Solid

Molecular weight: 288.36

Ref: TM-T70867